PATENT CLAIM ANALYSIS

Application Number: 15933596
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["424", "198100"]

Abstract:
A pharmaceutical composition and method for treating or attenuating a mood or stress-related disorder in a subject having normal or low inflammatory state is provided. In some embodiments, the pharmaceutical composition and method of the invention comprise activating or stimulating microglia for treatment of mood or stress-related disorder.

Claim (Index 1):
A method for treating or attenuating a major depressive disorder (MDD) in a subject having plasma C-reactive protein (CRP) levels lower than 3 mg/L, the method comprising administering to the subject a pharmaceutical composition comprising a therapeutically effective amount of a CX3C receptor 1 (CX3CR1) inhibitor and at least one pharmaceutically acceptable carrier or diluent.

Metadata:
- Claim Count in Document: 9.0
- Percentile: 90.0
- Lexical Diversity: 1.45714
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14913453', '15543914', '13581646', '12328625', '15110004']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.661132099942916
- 35 USC 102 Novelty (BERT): 0.501991770596882
- Combined Prediction Score: 0.6452180670083126
- Mean Citation Score: 196.11846
- Max Citation Score: 278.7317
- Similarity Product: 251.877840547657

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test